Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
21
datasets available to search
ShareScore release 0.9.0
Dataset results
21 results for “Olfactory Disorder”
The top 100 most influential articles in olfactory disorder: a bibliometric analysis
<p><strong>Introduction</strong><strong>:</strong> Studies on olfactory disorder have varied considerably in content and field over the past four decades. Influential publications of olfactory disorder have not been analyzed quantitatively. This study aimed to analyze the top 100 most influential articles in olfactory disorder through bibliometrics.</p> <p><strong>Methods:</strong> The researchers searched the Web of Science Core Collection for publications from 1980 to August 31, 2021. The top 100 highly cited articles were screened in accordance with the inclusion and exclusion criteria. The journal impact factor and the SCImago Journal Rank indicator were searched for the journal in which the top-cited articles were published. The researchers analyzed the data via Microsoft Excel and SPSS 24.0 and used VOSviewer software for data visualization.</p> <p><strong>Results:</strong> The total citations of the top 100 articles have increased exponentially, especially in the past 2 years. The journal LARYNGOSCOPE contributed the most influential papers (n=6). The United States published the most top 100 articles (n=52), followed by Germany and the United Kingdom. The University of Pennsylvania published the most influential studies, with a total of 3,852 citations. Richard L. Doty and Thomas Hummel contributed the most influential literature, and the top 100 studies also cited their research frequently. The most important articles in the field of OD mainly focused on COVID-19, Parkinson's disease and olfactory tests.</p> <p><strong>Conclusion:</strong> Neurodegenerative diseases and COVID-19-related olfactory disorders have been considered main topics over the past 40 years. This study identified the most influential articles for olfactory disorder researchers, providing guidance for their research.</p>
Data from: Olfactory testing in Parkinson's disease & REM behavior disorder: a machine learning approach
<p><span><span><span><span><span><span><span><span><span><span><span><b>Objective: </b></span></span></span></span></span></span></span></span></span></span></span><span><span><span><span><span><span><span><span><span><span><span>We sought to identify an abbreviated test of impaired olfaction, amenable for use in busy clinical environments in prodromal (isolated REM sleep Behavior Disorder (iRBD)) and manifest Parkinson's.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Methods: </b></span></span></span></span></span></span></span></span></span></span></span><span><span><span><span><span><span><span><span><span><span><span>890 PD and 313 control participants in the Discovery cohort study underwent Sniffin' stick odour identification assessment. Random forests were initially trained to distinguish individuals with poor (functional anosmia/hyposmia) and good (normosmia/super-smeller) smell ability using all 16 Sniffin' sticks. Models were retrained using the top 3 sticks ranked by order of predictor importance. One randomly selected 3-stick model was tested in a second independent Parkinson's dataset (n=452) and in two iRBD datasets (Discovery n=241; Marburg n=37) before being compared to previously described abbreviated Sniffin' stick combinations.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Results: </b></span></span></span></span></span></span></span></span></span></span></span><span><span><span><span><span><span><span><span><span><span><span>In differentiating poor from good smell ability, the overall area under the curve (AUC) value associated with the top 3 sticks (Anise, Licorice and Banana) was 0.95 in the development dataset (sensitivity:90%, specificity:92%, PPV:92%, NPV:90%). Internal and external validation confirmed AUCs≥0.90. The combination of 3-stick model determined poor smell and an RBD screening questionnaire score of ≥5, separated iRBD from controls with a sensitivity, specificity, PPV and NPV of 65%, 100%, 100% and 30%. </span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Conclusions: </b></span></span></span></span></span></span></span></span></span></span></span><span><span><span><span><span><span><span><span><span><span><span>Our 3-Sniffin'-stick model holds potential utility as a brief screening test in the stratification of individuals with Parkinson's and iRBD according to olfactory dysfunction.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Classification of Evidence: </b></span></span></span></span></span></span></span></span></span></span></span><span><span><span><span><span><span><span><span><span><span><span>This study provides Class III evidence that a 3-Sniffin'-stick model distinguishes individuals with poor and good smell ability and can be used to screen for individuals with iRBD.</span></span></span></span></span></span></span></span></span></span></span></p>
Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma
ClinicalTrials.gov study NCT04178616. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality
ClinicalTrials.gov study NCT04761458. IPD Sharing: Not stated. Countries: 1. Publications: 6.
COVID-19: Post-covid Olfactory Disorders Assessment
ClinicalTrials.gov study NCT04799977. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Pathogenesis of Olfactory Disorders in COVID-19
ClinicalTrials.gov study NCT04366934. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment
ClinicalTrials.gov study NCT06488807. IPD Sharing: NO. Countries: 1. Publications: 1.
Data from: Olfactory testing in Parkinson’s disease & REM behavior disorder: a machine learning approach
Open the record for dataset details and reuse information.
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
ClinicalTrials.gov study NCT06434818. IPD Sharing: NO. Countries: 1. Publications: 0.
Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
ClinicalTrials.gov study NCT02782988. IPD Sharing: NO. Countries: 1. Publications: 0.
Rapid Screening for Olfactory Disorders in Covid-19 Infection
ClinicalTrials.gov study NCT04696601. IPD Sharing: NO. Countries: 1. Publications: 0.
Self-assessment of Olfactory Disorders for French Speaking Patients
ClinicalTrials.gov study NCT04705805. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients
ClinicalTrials.gov study NCT04361565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19)
ClinicalTrials.gov study NCT04407494. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease
ClinicalTrials.gov study NCT06846658. IPD Sharing: YES. Countries: 1. Publications: 0.
Hypnotherapeutic Olfactory Conditioning for Posttraumatic Stress Disorder (PTSD)
ClinicalTrials.gov study NCT00784771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19
ClinicalTrials.gov study NCT05133596. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterization of Olfactory Perception in Post-Traumatic Stress Disorder
ClinicalTrials.gov study NCT06494306. IPD Sharing: NO. Countries: 1. Publications: 0.
REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
ClinicalTrials.gov study NCT04703218. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Olfactory Disorders in Patients With Cardiac Amyloidosis
ClinicalTrials.gov study NCT04661800. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.